Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer-Reference-Cited by-同舟云学术

Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer

Published:2007-11-27 Issue:1 Volume:98 Page:25-33
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Bernhard J, ,Zahrieh D,Zhang J J,Martinelli G,Basser R,Hürny C,Forbes J F,Aebi S,Yeo W,Thürlimann B,Green M D,Colleoni M,Gelber R D,Castiglione-Gertsch M,Price K N,Goldhirsch A,Coates A S

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6604092.pdf

Reference29 articles.

1. Basser RL, O’Neill A, Martinelli G, Green MD, Peccatori F, Cinieri S, Coates AS, Gelber RD, Aebi S, Castiglione-Gertsch M, Viale G, Price KN, Goldhirsch A (2006) Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of international breast cancer study group trial 15–95. J Clin Oncol 24: 370–378

2. Bernhard J, Hurny C, Coates AS, Peterson HF, Castiglione-Gertsch M, Gelber RD, Galligioni E, Marini G, Thurlimann B, Forbes JF, Goldhirsch A, Senn HJ, Rudenstam CM (1998) Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International breast cancer study group (IBCSG). Br J Cancer 78: 686–693

3. Bernhard J, Hurny C, Coates AS, Peterson HF, Castiglione-Gertsch M, Gelber RD, Goldhirsch A, Senn HJ, Rudenstam CM (1997) Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The international breast cancer study group. Ann Oncol 8: 825–835

4. Bernhard J, Maibach R, Thurlimann B, Sessa C, Aapro MS (2002) Patients’ estimation of overall treatment burden: why not ask the obvious? J Clin Oncol 20: 65–72

5. Bernhard J, Sullivan M, Hurny C, Coates AS, Rudenstam CM (2001) Clinical relevance of single item quality of life indicators in cancer clinical trials. Br J Cancer 84: 1156–1165

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment burden and cost-effectiveness analysis of the neoadjuvant CROSS regimen in esophageal squamous cell carcinoma: a multicenter retrospective study;Diseases of the Esophagus;2023-05-26

2. A Systematic Literature Review of Health Utility Values in Breast Cancer;Medical Decision Making;2022-01-18

3. A systematic literature review of the assessment of treatment burden experienced by patients and their caregivers;BMC Geriatrics;2019-10-11

4. Assessing health-related quality of life in patients with breast cancer: a reply to Maratia et al;Quality of Life Research;2017-09-05

5. Quality-adjusted time without symptoms or toxicity (Q-TWiST): patient-reported outcome or mathematical model? A systematic review in cancer;Psycho-Oncology;2014-06-11